Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 10, 2018

View Archived Issues

JZTX-V, compound isolated from Chilobrachys spider, found to restore learning and memory in AD

Shanghai Longwood Biopharmaceuticals divulges JAK inhibitors

Medshine Discovery and collaborator patent MAP3K5 inhibitors

Yafei Shanghai Biomedical Technology divulges drug conjugates for cancer

Shenzhen Targetrx Biotechnology discloses Bcr-Abl1 inhibitors

FDA approves Jornay PM extended-release capsules for the treatment of ADHD

AstraZeneca discovers JAK1 inhibitors

IMV reaches important milestones in advanced ovarian cancer clinical trial

Epilepsy-associated de novo variants in GABRs alter GABA(A) receptor function

Inhibitors of "undruggable" enzymes induce tumor arrest

Gemphire Therapeutics halts pediatric NAFLD study of gemcabene

New review on glyphosate evaluating mechanisms, regulatory framework and research prospects

I-Mab cleared to conduct clinical trial of TJ-103 in China

Petrovax Pharm's 4-valeant influenza vaccine --Grippol Quadrivalent-- approved in Russia

Global phase III trial of Celltrion's bevacizumab biosimilar begins

FDA approves Arakoda for prevention of malaria

Basilea Pharmaceutica starts second registrational phase III study of ceftobiprole

Phase III study of JCR Pharmaceuticals' JR-141 for Hunter syndrome begins

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...